A terminal cancer sufferer from Derbyshire has condemned the decision by the NHS drugs watchdog to withdraw the use of the drug Kadcyla to fight the disease on the grounds of cost.
The drug, which can add months to the life of women dying of breast cancer, costs £90,000 for a course of treatment.
The National Institute for Health and Care Excellence (Nice) said the drug was too expensive to recommend for widespread use in the health service.
Hayley Kalinins, from Borrowash, said: "How can they put a price on anybody's life?
"They do need to bring the cost of the drug down - that is obvious to everybody.
"It's been the miracle drug (for me). I've undergone four different types of chemotherapy before starting this drug.
"I've been on this drug for 18 weeks and experienced very minimal side effects from it, enabling me to have good family times with the four children."
More top news
The argument over the colour of this dress has been an internet sensation in the last 24 hours. Scientists explain why no one can agree.
The fashion company behind a dress that has sparked a massive internet colour debate is based in Erdington in Birmingham
Cloud will gradually thicken spread in from the west by dusk. Outbreaks of rain turning persistent later.